• Ben Goldacre:  Book discussion on Bad Pharma -  "Dr. Ben Goldacre talked about his book, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients, in which he discusses the influence of the pharmaceutical industry on the global healthcare system and argues that pharmaceutical companies hide negative studies and use questionable testing and intensive lobbying to get what they want, regardless of whether the drugs they produce are good for patients. Mr. Goldacre spoke about his book at Town Hall Seattle." February 18, 2013
  
  

• Ben Goldacre:  What doctors don't know about the drugs they prescribe - When a new drug gets tested, the results of the trials should be published for the rest of the medical world -- except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.
  
  
• Ben Goldacre:  Battling Bad Science  - Every day there are news reports of new health advice, but how can you know if they're right? Doctor and epidemiologist Ben Goldacre shows us, at high speed, the ways evidence can be distorted, from the blindingly obvious nutrition claims to the very subtle tricks of the pharmaceutical industry.
  
  
  • Teaching science by bad example: Q&A with Ben Goldacre  - TED’s Ben Lillie speaks with Ben Goldacre about how to read newspapers, the power of the placebo effect, and how people really want to learn if given the chance.
    
    

• Steve Woloshin:  What does the Cochrane logo tell us? - "This video and animated slide presentation prepared by Steven Woloshin shows how the Cochrane logo was developed, and what it tells us. The presentation explains relative risks, confidence intervals, forest plots, and standard and cumulative meta-analyses."
  
  
• David McCandless:  The Beauty of Data Visualization - David McCandless turns complex data sets into beautiful, simple diagrams that tease out unseen patterns and connections.
  
  
• Jer Thorp:  Make Data More Human - Jer Thorp creates beautiful data visualizations to put abstract data into a human context.

• Dr. David Sackett  - As the founder of Canadas first department of clinical epidemiology at McMaster University in Hamilton, Ontario in 1967, Dr. Sackett has made significant contributions to how we measure the presence of diseases in populations, and in particular how we assess the effectiveness of various forms of treatment.

• Overview of Pharma Industry Marketing practices (Part 1) -  Lisa A. Bero, Ph.D., UCSF School of Pharmacy, gives an overview of pharmaceutical industry marketing practices.

• Effects of Marketing on Prescribing:  Does Marketing Matter? - Lisa A. Bero, Ph.D., UCSF School of Pharmacy, discusses the effects of marketing on prescribing.

• Direct-to-Consumer Pharmaceutical Marketing - UCSF's Elizabeth Boyd discusses the regulation and effects of direct-to-consumer marketing

• Industry Sponsored Education and Marketing - UCSF's Kirby Lee discusses industry sponsored education used as marketing.

• Industry Sponsored Research and Marketing - UCSF's Dr. Thomas Newman discusses industry sponsored research used as marketing.

Gordon Guyatt:  The GRADE Approach I (this is a 12-part series - each segment is approximately 10 minutes long)

"The Grading of Recommendations Assessment, Development and Evaluation (short GRADE) Working Group began in the year 2000 as an informal collaboration of people with an interest in addressing the shortcomings of present grading systems in health care. The working group has developed a common, sensible and transparent approach to grading quality of evidence and strength of recommendations. Many international organizations have provided input into the development of the approach and have started using it." (taken from www.gradeworkinggroup.org).  Gordon Guyatt explains the GRADE approach in this lecture.

• Part 1:  Why grade recommendations?
• Part 2:  Categories of quality, consistency of results
• Part 3:  Sub-group analysis
• Part 4:  Subgroup analysis Q & A
• Part 5:  Indirect comparisons
• Part 6:  Reporting bias, observational studies, quality assessment criteria, overall assessment of evidence
  
• Part 7:  Crucial outcomes, strength of recommendation
• Part 8:  GRADE profiler
• Part 9:  What can lower quality?, recommendations
• Part 10:  Recommendations, Q & A
• Part 11:  Q & A 
• Part 12:  Q & A
  
  
  

The GRADE Approach II

• Is evidence-based medicine still the leading force in improving patient care?   Debate featuring Dr. Gordon Guyatt and Dr. Victor Montori
  
  
• Power of the test, p-values, publication bias and statistical evidence - A discussion of statistical evidence and why you might not get results significant enough to reject your null hypothesis even if your alternative hypothesis is correct.
  
  
  

A.5   Lectures

• Iain Chalmers:  Fundamental Failings in Clinical Research - Sir Iain Chalmers rips into clinical researchers for not understanding what is know, not stating clearly what their research adds, and not publishing negative or 'disappointing' results.
  
  
• Gordon Guyatt:  Overview of meta-analysis and methods -
  
  
• Gordon Guyatt:  Is Canadian Healthcare Unsustainable? - Can Canada afford universal public healthcare?

• Iain Chalmers:  The Life Scientific [mp3] - Trained as a physician, Sir Iain Chalmers became a champion for treatments based on the best available evidence and the first director of The Cochrane Collaboration.
  

• David Moher:  A methodology for conducting rapid evidence reviews
• Kay Dickersin:  Comparative Effectiveness Research: An Opportunity to Collaborate Across Disciplines
  
• Kay Dickersin:  The Cochrane Collaboration:  Working Together to Provide the Best Evidence for Health Care
  
• G-I-N North America Webinar Series
• AHRQ Webinar:  Using Deliberative Methods to Engage Patients, Consumers, and the Public.
• Steve Goodman:  What to know about statistics to ask the right questions.
  

• FDA Sentinel Initiative